Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 1/20 | 0.50 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.30 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27580351 | 0.89 | DGAT1 (0.45) | DGAT1ELANE | |
| SCHEMBL22773965 | 0.82 | TDP1 (0.32) | DGAT1ALDH1A1TDP1FFAR3 | |
| SCHEMBL4463447 | 0.81 | DGAT1 (0.46) | DGAT1ELANETSHRALDH1A1FFAR3 | |
| SCHEMBL2443587 | 0.78 | SOAT1 (0.44) | TSHRALDH1A1 | |
| SCHEMBL2313446 | 0.78 | DGAT1 (0.48) | DGAT1ELANETSHRKCNN4 | |
| SCHEMBL27328998 | 0.78 | DGAT1 (0.54) | DGAT1ELANETDP1CA1 | |
| SCHEMBL3576946 | 0.78 | DGAT1 (0.48) | DGAT1ELANETSHRKCNN4ALDH1A1 | |
| SCHEMBL2545646 | 0.78 | ALDH1A1 (0.41) | TSHRALDH1A1TDP1FFAR3 | |
| SCHEMBL808799 | 0.78 | DGAT1 (0.74) | DGAT1ELANETSHRKCNN4ALDH1A1 | |
| SCHEMBL3646518 | 0.78 | DGAT1 (0.43) | DGAT1ALDH1A1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117844358-A | Thermal sublimation coating liquid and preparation method thereof | 湖南肆玖科技有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-103772282-A | Method for preparing 3-tertiary butyl-1H-pyrazole-4-formaldehyde | BIDE PHARMATECH LTD | 2014-05-07 | — | — | CN | claimed |
| CN-119101081-A | Metal-containing film-forming compound, metal-containing film-forming composition, method for producing metal-containing film-forming compound, and pattern-forming method | 信越化学工业株式会社 | 2024-12-10 | — | — | CN | disclosed |
| CN-117940518-A | Active energy ray-curable primer, undercoat layer, laminate, and metal film-coated substrate | 爱天思株式会社 | 2024-04-26 | — | — | CN | disclosed |
| CN-117844358-A | Thermal sublimation coating liquid and preparation method thereof | 湖南肆玖科技有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-117363058-A | Composition for forming metal oxide film, pattern forming method, and metal oxide film forming method | 信越化学工业株式会社 | 2024-01-09 | — | — | CN | disclosed |
| CN-114206830-A | Alcohol derivatives as Kv7 potassium channel openers | H.隆德贝克有限公司 | 2022-03-18 | — | — | CN | disclosed |
| CN-106471626-A | Composition for forming passivation layer, semiconductor substrate with passivation layer and manufacturing method thereof, solar cell element and manufacturing method thereof, and solar cell | 日立化成株式会社 | 2017-03-01 | — | — | CN | disclosed |
| CN-102041482-B | Containing the deposition method of the film of group-4 metal | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2015-08-19 | — | — | CN | disclosed |
| CN-104081504-A | Composition for forming passivation film, semiconductor substrate provided with passivation film and method for producing same, and solar cell element and method for producing same | HITACHI CHEMICAL CO LTD | 2014-10-01 | — | — | CN | disclosed |
| CN-104040701-A | Semiconductor substrate with passivation film and method for manufacturing same, and solar cell element and method for manufacturing same | HITACHI CHEMICAL CO LTD | 2014-09-10 | — | — | CN | disclosed |
| EP-1480640-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS | ELI LILLY AND COMPANY (US) | 2004-12-01 | — | — | EP | disclosed |
| WO-2004092131-A1 | INDOLE DERIVATIVES AS PPAR MODULATORS | ELI LILLY AND COMPANY (US) | 2004-10-28 | — | — | WO | disclosed |
| WO-2004063190-A1 | FUSED HETEROCYCLIC DERIVATES AS PPAR MODULATORS | ELI LILLY AND COMPANY (US) | 2004-07-29 | — | — | WO | disclosed |
| WO-2003072100-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS | ELI LILLY AND COMPANY (US) | 2003-09-04 | — | — | WO | disclosed |
| US-6603033-B2 | Used as sources of titanium dioxide for metal-organic chemical vapor deposition (MOCVD) | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2003-08-05 | — | — | US | disclosed |
| CN-1109675-C | Aryl pyrimidine derivatives | HOFFMANN LA ROCHE (CH) | 2003-05-28 | — | — | CN | disclosed |
| US-20030040638-A1 | Organotitanium precursors for chemical vapor deposition and manufacturing method thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2003-02-27 | — | — | US | disclosed |
| US-20020143201-A1 | Organotitanium precursors and manufacturing method thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2002-10-03 | — | — | US | disclosed |
| CN-1223641-A | Aryl pyrimidine derivatives | HOFFMANN LA ROCHE (CH) | 1999-07-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020143201-A1 | Organotitanium precursors and manufacturing method thereof | TKT, KMT5A, TST | DGAT1 896/4885ELANE 4409/4885TSHR 2932/4885 |
| US-20030040638-A1 | Organotitanium precursors for chemical vapor deposition and manufacturing method thereof | TKT, ADH5, KYAT1 | DGAT1 1136/4885ELANE 4379/4885TSHR 1233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.